Shao Yuekai

1 clinical trials · Sponsor

Record	Firm	Date
The Value of Serum MicroRNA-21-5p and LncRNAgadd7 Expression Levels in Predicting the Severity and Prognosis of ARDS ( Acute Respiratory Distress Syndrome ) (NCT06825754)	Shao Yuekai	2023-11-01

Every clearance here is in the API, with alerts when new ones post.